Neuromodulation Society of Australia and New Zealand (NSANZ) NSANZ logo

Welcome!

Dr James Yu -  president
Dr Nick Christelis - immediate past president
Dr Alan Nazha - treasurer
Megan Hannah - secretary
Dr Marc Russo - director at large
Dr Murray Taverner - director at large
Dr Mo Awad - director
Dr Roger Tan - director
Rachel Whipp - director
Dr Nathan Taylor - director
Dr Michelle O'Brien - scientific convenor

Contact: [email protected]

Learn more about joining.

NSANZ Website

NSANZ Constitution


NSANZ Events

NSANZ Webinar
Wednesday, 28 February 2023
https://dcconferences.eventsair.com/nsanz-webinar-series/


NSANZ 2023, 16th Annual Scientific Meeting
12-13 August 2023
Sofitel Brisbane Central, QLD
www.dcconferences.com.au/nsanz2023
16th NSANZ ASM Save the Date Flyer

 2023 NSANZ ASM

 


Historical Events

NSANZ Webinar
Tuesday, 29 November 2022
https://dcconferences.eventsair.com/nsanz-webinar-series/

NSANZ Webinar Nov. 22

2022 Neuromodulation Society of Australia and New Zealand 15th Annual Scientific Meeting (NSANZ 2022)
13-14 August 2022

Melbourne, Australia
Website: https://www.dcconferences.com.au/nsanz2022/

NSANZ Safety Webinar Series
Save the date: Tuesday, 17 May 2022, 7:00 p.m. (AEST)

https://dcconferences.com.au/nsanz-webinar-series

NSANZ Safety Webinar Series
Tuesday 14 September 2021 & 30 November 2021
Website: https://dcconferences.com.au/nsanz-webinar-series

2021 Neuromodulation Society of Australia and New Zealand 14th Annual Scientific Meeting (NSANZ 2021)
Saturday 14 August - Sunday 15 August 2021
Virtual Conference

Neuromodulation Society of Australia and New Zealand (NSANZ) Cadaver Workshop
Saturday 17 April 2021
Macquarie University, Sydney

Neuromodulation Society of Australia and New Zealand 14th Annual Scientific Meeting
13-15 August 2021
Sofitel Brisbane Central, Queensland

Neuromodulation Society of Australia and New Zealand (NSANZ) Cadaver Workshop
Friday 13 August 2021

QUT Medical Engineering Facility (MERF), The Prince Charles Hospital, Brisbane

2019 Deloitte Access Economics Report: Cost Effectiveness of Pain Devices

The Neuromodulation Society of Australia and New Zealand (NSANZ), engaged Deloitte Access Economics to estimate the cost effectiveness of neuromodulation treatment through spinal cord stimulation (SCS) and intrathecal pumps, which are collectively referred to as pain devices.

Click here for the full report.

We will keep you informed of any updates.

 

Last Updated on Tuesday, December 20, 2022 04:04 PM